# Roberto Salgado

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/roberto-salgado/

## Facts

| Field | Value |
| --- | --- |
| Citations | 39,435 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 83 |
| i10-index | 194 |
| Last Known Institution | Peter MacCallum Cancer Centre |
| OpenAlex ID | https://openalex.org/A5016015665 |
| ORCID iD | https://orcid.org/0000-0002-1110-3801 |
| Works | 600 |

## Researcher papers

- [The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014](https://scholariq.org/papers/the-evaluation-of-tumor-infiltrating-lymphocytes-tils-in-breast-cancer/)
- [The 2019 World Health Organization classification of tumours of the breast](https://scholariq.org/papers/the-2019-world-health-organization-classification-of-tumours-of-the-breast/)
- [Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors](https://scholariq.org/papers/assessing-tumor-infiltrating-lymphocytes-in-solid-tumors-a-practical-review-for/)
- [Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group](https://scholariq.org/papers/assessment-of-ki67-in-breast-cancer-updated-recommendations-from-the/)
- [Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research](https://scholariq.org/papers/assessing-tumor-infiltrating-lymphocytes-in-solid-tumors-a-practical-review-for-2/)
- [Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy](https://scholariq.org/papers/melanoma-specific-mhc-ii-expression-represents-a-tumour-autonomous-phenotype-and/)
- [The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group](https://scholariq.org/papers/the-tale-of-tils-in-breast-cancer-a-report-from-the-international-immuno/)
- [Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma](https://scholariq.org/papers/determinants-of-anti-pd-1-response-and-resistance-in-clear-cell-renal-cell/)
- [The evolution of non-small cell lung cancer metastases in TRACERx](https://scholariq.org/papers/the-evolution-of-non-small-cell-lung-cancer-metastases-in-tracerx/)
- [RETRACTED ARTICLE: Antibodies against endogenous retroviruses promote lung cancer immunotherapy](https://scholariq.org/papers/retracted-article-antibodies-against-endogenous-retroviruses-promote-lung-cancer/)
- [Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project](https://scholariq.org/papers/aligning-tumor-mutational-burden-tmb-quantification-across-diagnostic-platforms/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Cancer Cells and Metastasis](https://scholariq.org/topics/cancer-cells-and-metastasis/)

## Researcher university

- [Peter MacCallum Cancer Centre](https://scholariq.org/institutions/peter-maccallum-cancer-centre/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.